Instil Bio (TIL) Other Non-Current Assets (2020 - 2026)
Instil Bio (TIL) posted Other Non-Current Assets of $3.9 million for Q2 2026, down 1.93% on a QoQ basis from $4.0 million in Q1 2026, and down 65.1% year-over-year from $11.2 million in Q2 2025.
Analysis
Instil Bio (TIL) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Instil Bio has reported Other Non-Current Assets for 7 years, with the latest figure at $3.9 million in Q2 2026.
- On a quarterly basis, Other Non-Current Assets fell 65.1% year-over-year to $3.9 million in Q2 2026; TTM through Jun 2026 was $3.9 million, a 65.1% decrease from a year earlier, with the FY2025 full-year figure at $4.1 million, down 9.44% from the prior year.
- Other Non-Current Assets was $3.9 million for Q2 2026 at Instil Bio, down from $4.0 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $11.2 million in Q2 2025, with the low at $581000.0 in Q2 2024.
- Average Other Non-Current Assets over 5 years is $4.3 million, with a median of $3.9 million recorded in 2026.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets tumbled 81.25% in 2024, then soared 1827.88% in 2025.
- Over 5 years, Other Non-Current Assets stood at $3.4 million in 2022, then sank by 56.02% to $1.5 million in 2023, then soared by 199.13% to $4.5 million in 2024, then slipped by 9.44% to $4.1 million in 2025, then retreated by 3.86% to $3.9 million in 2026.
- The last three Other Non-Current Assets figures came in at $3.9 million (Q2 2026), $4.0 million (Q1 2026), and $4.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 12.98 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 4.75 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 2.31 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 124.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 618.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 831.80 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 29.59 Mn |
| 10 | Instil Bio | 50.19 Mn | 50.19 Mn | - | 3.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.91 Mn |
| Mar 31, 2026 | 3.99 Mn |
| Dec 31, 2025 | 4.07 Mn |
| Sep 30, 2025 | 4.15 Mn |
| Jun 30, 2025 | 11.20 Mn |
| Mar 31, 2025 | 10.07 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Jun 30, 2024 | 581,000.00 |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 2.54 Mn |
| Jun 30, 2023 | 3.10 Mn |
| Mar 31, 2023 | 3.63 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Sep 30, 2022 | 5.01 Mn |
| Jun 30, 2022 | 4.25 Mn |
| Mar 31, 2022 | 3.08 Mn |
| Dec 31, 2021 | 8.14 Mn |
| Sep 30, 2021 | 4.79 Mn |